Hereditary Gynecologic Cancer Syndromes – A Narrative Review

References

• Devlin LA, Morrison PJ. Inherited gynaecological cancer syndromes. Obstetr Gynaecolog. 2008;10(1):9–15. doi:10.1576/toag.10.1.009.27371
   Google Scholar
• Daniels MS, Lu KH. Genetic predisposition in gynecologic cancers. Semin Oncol. 2016;43(5):543–547. doi:10.1053/j.seminoncol.2016.08.005
   PubMed Web of Science ®Google Scholar
• Chen L, Blank SV, Burton E, Glass K, Penick E, Woodard T. Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for reproductive medicine evidence-based review. Gynecol Oncol. 2019;155:508–514. doi:10.1016/j.ygyno.2019.06.017
   PubMed Web of Science ®Google Scholar
• Kehoe SM, Kauff ND. Screening and prevention of hereditary gynecologic cancers. Semin Oncol. 2007;34(5):406–410. doi:10.1053/j.seminoncol.2007.07.004
   PubMed Web of Science ®Google Scholar
• Randall LM, Pothuri B. The genetic prediction of risk for gynecologic cancers. Gynecol Oncol. 2016;141(1):10–16. doi:10.1016/j.ygyno.2016.03.007
   PubMed Web of Science ®Google Scholar
• Lu KH. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis. Fam Cancer. 2007;7(1):53–58. doi:10.1007/s10689-007-9144-x
   PubMed Web of Science ®Google Scholar
• Brown GJE, St. John DJB, Macrae FA, Aittomäki K. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance. Gynecol Oncol. 2001;80(3):346–349. doi:10.1006/gyno.2000.6065
   PubMed Web of Science ®Google Scholar
• Idos G, Valle L. Lynch syndrome. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews^®. Seattle: University of Washington, Seattle; 2004:1993–2021.
   Google Scholar
• Mutch D, Denny L, Quinn M. Hereditary gynecologic cancers. Int Jurnal of Gynecol Obstetr. 2013;124(3):189–192. doi:10.1016/j.ijgo.2013.12.001
   PubMed Web of Science ®Google Scholar
• Shanbhogue KP, Prasad AS, Ucisik-Keser FE, Katabathina VS, Morani AC. Hereditary ovarian tumour syndromes: current update on genetics and imaging. Clin Radiol. 2021;76:313.e15–313.e26. doi:10.1016/j.crad.2020.11.116
   PubMed Web of Science ®Google Scholar
• Nakamura K, Banno K, Yanokura M, et al. Features of ovarian cancer in Lynch syndrome (Review). Mol Clin Oncol. 2014;2(6):909–916. doi:10.3892/mco.2014.397
   PubMedGoogle Scholar
• Bartosch C, Clarke B, Bosse T. Gynaecological neoplasms in common familial syndromes (Lynch and HBOC). Pathology. 2018;50(2):222–237. doi:10.1016/j.pathol.2017.10.010
   PubMed Web of Science ®Google Scholar
• Davidson SA. Hereditary gynecologic cancer syndromes. Postgrad Obstetr Gynecol. 2010;30(1):1–7. doi:10.1097/01.pgo.0000364891.73439.70
   Google Scholar
• Goetsch AL, Kimelman D, Woodruff TK. Hereditary gynecologic cancer predisposition syndromes. In: Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Springer; 2017:7–18. doi:10.1007/978-3-319-52316-3_2
   Google Scholar
• Lu KH, Dinh M, Kohlmann W, et al. Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005;105(3):569–574. doi:10.1097/01.aog.0000154885.44002.ae
   PubMed Web of Science ®Google Scholar
• Makabe T, Yamagami W, Hirasawa A, et al. Incidence of germline variants in lynch syndrome-related genes among Japanese endometrial cancer patients aged 40 years or younger. Int J Clin Oncol. 2021;26:1767–1774. doi:10.1007/s10147-021-01953-5
   PubMed Web of Science ®Google Scholar
• Cohen SA, Pritchard CC, Jarvik GP. Lynch syndrome: from screening to diagnosis to treatment in the era of modern molecular oncology. Annu Rev Genomics Hum Genet. 2019;20(1):293–307. doi:10.1146/annurev-genom-083118-015406
   PubMed Web of Science ®Google Scholar
• Post CCB, Stelloo E, Smit VT, et al. Prevalence and prognosis of lynch syndrome and sporadic mismatch repair deficiency in endometrial cancer. J Natl Cancer Inst. 2021;113(9):1212–1220. doi:10.1093/jnci/djab029
   PubMedGoogle Scholar
• Dominguez-Valentin M, Plazzer J-P, Sampson JR, et al. No difference in penetrance between truncating and missense/aberrant splicing pathogenic variants in MLH1 and MSH2: a prospective lynch syndrome database study. J Clin Med. 2021;10:2856. doi:10.3390/jcm10132856
   PubMed Web of Science ®Google Scholar
• Findeis-Hosey J, Gonzalez RS. Lynch syndrome. Available from: https://www.pathologyoutlines.com/topic/colontumorlynch.html. Accessed February 7, 2021.
   Google Scholar
• Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2020. doi:10.1136/ijgc-2020-002230
   Web of Science ®Google Scholar
• Møller P, Seppälä T, Bernstein I, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017;66:464–472. doi:10.1136/gutjnl-2015-309675
   PubMed Web of Science ®Google Scholar
• Tanakaya K. Current clinical topics of Lynch syndrome. Int J Clin Oncol. 2018;24:1013–1019. doi:10.1007/s10147-018-1282-7
   PubMed Web of Science ®Google Scholar
• Vasen H, Watson P, Mecklin J, Lynch H. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆. Gastroenterology. 1999;116(6):1453–1456. doi:10.1016/s0016-5085(99)
   PubMed Web of Science ®Google Scholar
• Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96(4):261–268. doi:10.1093/jnci/djh034
   PubMed Web of Science ®Google Scholar
• Duraturo F, Liccardo R, De Rosa M, Izzo P. Genetics, diagnosis and treatment of Lynch syndrome: old lessons and current challenges (Review). Oncol Lett. 2019. doi:10.3892/ol.2019.9945
   PubMed Web of Science ®Google Scholar
• Buchanan DD, Tan YY, Walsh MD, et al. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. J Clin Oncol. 2014;32:90–100. 45. doi:10.1200/JCO.2013.51.2129
   PubMed Web of Science ®Google Scholar
• Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol. 2014;38:1501–1509. doi:10.1097/PAS.0000000000000321
   PubMed Web of Science ®Google Scholar
• Aarnio M. Clinicopathological features and management of cancers in lynch syndrome. Patholog Res Int. 2012;2012:1–6. doi:10.1155/2012/350309
   Google Scholar
• Walsh S. The pathology of lynch syndrome. Diagn Histopathol. 2015;21(4):161–164. doi:10.1016/j.mpdhp.2015.04.007
   Google Scholar
• WHO. Female Genital Tumors, World Health Organization Classification of Tumours. 5th ed. Edited by the WHO of Classification of Tumours Editorial Board; 1980.
   Google Scholar
• Zhao S, Chen L, Zang Y, et al. Endometrial cancer in Lynch syndrome. Int J Cancer. 2021. doi:10.1002/ijc.33763
   Web of Science ®Google Scholar
• Broaddus RR, Lynch HT, Chen LM, et al. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer. 2006;106:87–94. doi:10.1002/cncr.21560
   PubMed Web of Science ®Google Scholar
• Westin SN, Lacour RA, Urbauer DL, et al. Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. J Clin Oncol. 2008;26:5965–5971. doi:10.1200/JCO.2008.18.6296
   PubMed Web of Science ®Google Scholar
• Jensen KC, Mariappan MR, Putcha GV, et al. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Am J Surg Pathol. 2008;32(7):1029–1037. doi:10.1097/PAS.0b013e31816380c4
   PubMed Web of Science ®Google Scholar
• Ryan NAJ, Evans DG, Green K, Crosbie EJ. Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer. Gynecol Oncol. 2017;144(3):491–495. doi:10.1016/j.ygyno.2017.01.005
   PubMed Web of Science ®Google Scholar
• Sheehan M, Heald B, Yanda C, et al. Investigating the link between lynch syndrome and breast cancer. Eur J Breast Health. 2020;16(2):106–109. doi:10.5152/ejbh.2020.5198
   PubMed Web of Science ®Google Scholar
• Walsh MD, Buchanan DD, Cummings MC, et al. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010;16(7):2214–2224. doi:10.1158/1078-0432.CCR-09-3058
   PubMed Web of Science ®Google Scholar
• Yee CJ, Roodi N, Verrier CS, Parl FF. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res. 1994;54:1641–1644.
   PubMed Web of Science ®Google Scholar
• Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control. 2009;16(1):14–22. doi:10.1177/107327480901600103
   PubMed Web of Science ®Google Scholar
• Dominguez-Valentin M, Crosbie EJ, Engel C, et al. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a prospective lynch syndrome database report. Genet Med. 2021;23:705–712. doi:10.1038/s41436-020-01029-1
   PubMed Web of Science ®Google Scholar
• Tzortzatos G, Andersson E, Soller M, et al. The gynecological surveillance of women with Lynch syndrome in Sweden. Gynecol Oncol. 2015;138(3):717–722. doi:10.1016/j.ygyno.2015.07.016
   PubMed Web of Science ®Google Scholar
• Dueñas N, Navarro M, Teulé À, et al. Assessing effectiveness of colonic and gynecological risk reducing surgery in lynch syndrome individuals. Cancers. 2020;12(11):3419. doi:10.3390/cancers12113419
   PubMed Web of Science ®Google Scholar
• Seppälä TT, Dominguez-Valentin M, Crosbie EJ, et al. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a prospective lynch syndrome database report. Eur J Cancer. 2021;148:124–133. doi:10.1016/j.ejca.2021.02.022
   PubMed Web of Science ®Google Scholar
• Toss A, Tomasello C, Razzaboni E, et al. Hereditary ovarian cancer: not OnlyBRCA1 and 2 genes. Biomed Res Int. 2015;2015:1–11. doi:10.1155/2015/341723
   Web of Science ®Google Scholar
• Prat J, Ribé A, Gallardo A. Hereditary ovarian cancer. Hum Pathol. 2005;36(8):861–870. doi:10.1016/j.humpath.2005.06.006
   PubMed Web of Science ®Google Scholar
• Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G. Hereditary ovarian cancer. Crit Rev Oncol/ Hematol. 2009;69(1):28–44. doi:10.1016/j.critrevonc.2008.06.003
   PubMed Web of Science ®Google Scholar
• Petrucelli N, Daly MB, Pal T, et al. BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews^®. Seattle: University of Washington, Seattle; 1998:1993–2021.
   Google Scholar
• Nakonechny QB, Gilks CB. Ovarian cancer in hereditary cancer susceptibility syndromes. Surg Pathol Clin. 2016;9(2):189–199. doi:10.1016/j.path.2016.01.003
   PubMedGoogle Scholar
• Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2020. doi:10.1007/s12282-020-01148-2
   Web of Science ®Google Scholar
• George SH, Garcia R, Slomovitz BM. Ovarian cancer: the fallopian tube as the site of origin and opportunities for prevention. Front Oncol. 2016;6:108. doi:10.3389/fonc.2016.00108
   PubMed Web of Science ®Google Scholar
• Sakurada S, Watanabe Y, Tokunaga H, et al. Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women. Jpn J Clin Oncol. 2018;48(9):794–798. doi:10.1093/jjco/hyy095
   PubMed Web of Science ®Google Scholar
• Fanale D, Pivetti A, Cancelliere D, et al. BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: looking for the hidden meaning. Crit Rev Oncol Hematol. 2022;172:103626. doi:10.1016/j.critrevonc.2022.103626
   PubMed Web of Science ®Google Scholar
• Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Rahman N. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet. 2011;43(9):879–882. doi:10.1038/ng.893
   PubMed Web of Science ®Google Scholar
• Meindl A, Hellebrand H, Wiek C, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42(5):410–414. doi:10.1038/ng.569
   PubMed Web of Science ®Google Scholar
• Rafnar T, Gudbjartsson DF, Sulem P, et al. Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet. 2011;43(11):1104–1107. doi:10.1038/ng.955
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Log in page. Available from: https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf. Accessed November 20, 2021.
   Google Scholar
• Evans DG, Clayton R, Donnai P, Shenton A, Lalloo F. Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk. Eur J Human Genet. 2009;17(11):1381–1385. doi:10.1038/ejhg.2009.60
   PubMed Web of Science ®Google Scholar
• Liu YL, Breen K, Catchings A, et al. Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: a review and clinical guide for hereditary predisposition genes [published online ahead of print, 2021 Sep 28]. JCO Oncol Pract. 2021;OP2100382. doi:10.1200/OP.21.00382
   Google Scholar
• Öfverholm A, Einbeigi Z, Wigermo A, Holmberg E, Karsson P. Increased overall mortality even after risk reducing surgery for BRCA-positive women in Western Sweden. Genes. 2019;10(12):1046. doi:10.3390/genes10121046
   PubMed Web of Science ®Google Scholar
• Manning-Geist BL, Gatius S, Liu Y, et al. Diagnosis and management of an endometrial cancer patient with Cowden syndrome. Gynecol Oncol. 2021;163:14–21. doi:10.1016/j.ygyno.2021.08.00
   PubMed Web of Science ®Google Scholar
• Ueki A, Hirasawa A. Molecular features and clinical management of hereditary gynecological cancers. Int J Mol Sci. 2020;21(24):9504. doi:10.3390/ijms21249504
   PubMed Web of Science ®Google Scholar
• Baker WD, Soisson AP, Dodson MK. Endometrial cancer in a 14-year-old girl with Cowden syndrome: a case report. J Obstetr Gynaecol Res. 2012;39(4):876–878. doi:10.1111/j.1447-0756.2012.02052.x
   PubMed Web of Science ®Google Scholar
• Schmeler KM, Daniels MS, Brandt AC, Lu KH. Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome. Obstet Gynecol. 2009;114(2 Pt 2):477–479. doi:10.1097/AOG.0b013e31819dade8
   PubMed Web of Science ®Google Scholar
• Heaney RM, Farrell M, Stokes M, Gorey T, Murray D. Cowden syndrome: serendipitous diagnosis in patients with significant breast disease. Case series and literature review. Breast J. 2016;23(1):90–94. doi:10.1111/tbj.12691
   PubMed Web of Science ®Google Scholar
• El-Halaby A, Gonzalez R. Cowden syndrome. Available from: https://www.pathologyoutlines.com/topic/colontumorcowden.html. Accessed March 3, 2021.
   Google Scholar
• Katabathina VS, Menias CO, Khanna L, et al. Hereditary gastrointestinal cancer syndromes: role of imaging in screening, diagnosis, and management. RadioGraphics. 2019;180185. doi:10.1148/rg.2019180185
   Web of Science ®Google Scholar
• Mahdi H, Mester JL, Nizialek EA, Ngeow J, Michener C, Eng C. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study. Cancer. 2015;121(5):688–696. doi:10.1002/cncr.29106
   PubMed Web of Science ®Google Scholar
• George A, Gheena S. Li- Fraumeni syndrome- a review. Int J Sci Eng Dev Res. 2017;2(8):154–159.
   Google Scholar
• Farid M, Ngeow J. Sarcomas associated with genetic cancer predisposition syndromes: a review. Oncologist. 2016;21(8):1002–1013. doi:10.1634/theoncologist.2016-0079
   PubMed Web of Science ®Google Scholar
• Neto N, Cunha TM. Do hereditary syndrome-related gynecologic cancers have any specific features? Insights Imaging. 2015;6(5):545–552. doi:10.1007/s13244-015-0425-x
   PubMedGoogle Scholar
• Gupta A, Malkin D. Sarcomas and cancer predisposition syndromes. Available from: http://sarcomahelp.org/articles/sarcoma-predisposition-syndromes.html. Accessed March 06, 2021.
   Google Scholar
• George S, Serrano C, Hensley ML, Ray-Coquard I. Soft tissue and uterine leiomyosarcoma. J Clin Oncol. 2018;36(2):144–150. doi:10.1200/JCO.2017.75.9845
   PubMed Web of Science ®Google Scholar
• Clark MB, Menderes G, Azodi M, Finberg K, Canosa S, Parkash V. Endometrial carcinoma as the presenting malignancy in an 18-year-old patient with Li-Fraumeni syndrome. Gynecol Oncol. 2016;141:183–184. doi:10.1016/j.ygyno.2016.04.473
   Google Scholar
• Bougeard G, Renaux-Petel M, Flaman J-M, et al. Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33(21):2345–2352. doi:10.1200/jco.2014.59.5728
   PubMed Web of Science ®Google Scholar
• Kuba MG, Lester SC, Bowman T, et al. Histopathologic features of breast cancer in Li–Fraumeni syndrome. Mod Pathol. 2020. doi:10.1038/s41379-020-0610-4
   Web of Science ®Google Scholar
• Andon B, Hagemann IS, Maluf HM, Pfeifer JD, Al-Kateb H. Association of Li-Fraumeni syndrome with small cell carcinoma of the ovary, hypercalcemic type and concurrent pleomorphic liposarcoma of the cervix. Int J Gynecol Pathol. 2017;36(6):593–599. doi:10.1097/PGP.0000000000000365
   PubMed Web of Science ®Google Scholar
• Meserve EEK, Nucci MR. Peutz-Jeghers Syndrome. Surg Pathol Clin. 2016;9(2):243–268. doi:10.1016/j.path.2016.01.006
   PubMedGoogle Scholar
• Ishida H, Tajima Y, Gonda T, Kumamoto K, Ishibashi K, Iwama T. Update on our investigation of malignant tumors associated with Peutz–Jeghers syndrome in Japan. Surg Today. 2016;46(11):1231–1242. doi:10.1007/s00595-015-1296-y
   PubMed Web of Science ®Google Scholar
• Banno K, Kisu I, Yanokura M, et al. Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review). Oncol Lett. 2013;6(5):1184–1188. doi:10.3892/ol.2013.1527
   PubMed Web of Science ®Google Scholar
• Chen H-Y, Jin X-W, Li B-R, et al. Cancer risk in patients with Peutz–Jeghers syndrome: a retrospective cohort study of 336 cases. Tumor Biol. 2017;39(6):101042831770513. doi:10.1177/1010428317705131
   Google Scholar
• Kim Y, Kim EY, Kim TJ, et al. A rare case of gastric-type mucinous adenocarcinoma in a woman with Peutz-Jeghers syndrome. Obstetr Gynecol Sci. 2019;62(6):474–477. doi:10.5468/ogs.2019.62.6.474
   PubMedGoogle Scholar
• Turashvili G. Gastric type adenocarcinoma. PathologyOutlines.com website. Available from: https://www.pathologyoutlines.com/topic/cervixGAS.html. Accessed March 7, 2021.
   Google Scholar
• Gálvez-Cuitiva EA, Ridaura-Sanz C, Yamazaki-Nakashimada MA, et al. Germ cell ovarian tumor in an adolescent with ataxia-telangiectasia. Acta Pediatr Mex. 2015;36(6):464–472. doi:10.18233/APM36No6pp464-472
   Google Scholar
• Pecorelli S, Sartori E, Favalli G, Ugazio AG, Gastaldi A. Ataxia-telangiectasia and endodermal sinus tumor of the ovary: report of a case. Gynecol Oncol. 1988;29(2):240–244. doi:10.1016/0090-8258(88)90219-3
   PubMed Web of Science ®Google Scholar
• Cao J, Tan RYC, Li S-T, et al. Identifying ataxia-telangiectasia in cancer patients: novel insights from an interesting case and review of literature. Clin Case Rep. 2021;9:995–1009. doi:10.1002/ccr3.3543
   PubMed Web of Science ®Google Scholar
• Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11(1):159. doi:10.1186/s13023-016-0543-7
   PubMed Web of Science ®Google Scholar
• Veiga-Fernández A, Perdigón MD, Claverol MB, et al. 194 Ataxia-teleangiectasia followed up in a hereditary gynaecological cancer unit of a tertiary hospitalInternational. J Gynecolog Cancer. 2020;30:A91–A92.
   Web of Science ®Google Scholar
• Gatti RA, Nieberg R, Boder E. Uterine tumors in ataxia-telangiectasia. Gynecol Oncol. 1989;32(2):257–260. doi:10.1016/s0090-8258(89)
   PubMed Web of Science ®Google Scholar
• Caroleo AM, De Ioris MA, Boccuto L, et al. DICER1 syndrome and cancer predisposition: from a rare pediatric tumor to lifetime risk. Front Oncol. 2021;10:614541. doi:10.3389/fonc.2020.614541
   PubMed Web of Science ®Google Scholar
• Brenneman M, Field A, Yang J, et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma/ DICER1 syndrome: a unique variant of the two-hit tumor suppression model. F1000Res. 2015;4:214. doi:10.12688/f1000research.6746.1
   PubMedGoogle Scholar
• González IA, Stewart DR, Schultz KAP, et al. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathol. 2022;35:4–22. doi:10.1038/s41379-021-00905-8
   PubMed Web of Science ®Google Scholar
• Schultz KAP, Williams GM, Kamihara J, et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res. 2018;24(10):2251–2261. doi:10.1158/1078-0432.CCR-17-3089
   PubMed Web of Science ®Google Scholar
• Kim J, Field A, Schultz KAP, Hill DA, Stewart DR. The prevalence of DICER1 pathogenic variation in population databases. Int J Cancer. 2017;141:2030–2036. doi:10.1002/ijc.30907
   PubMed Web of Science ®Google Scholar
• Hayes K, French A. Pediatric gynecologic malignancy and DICER1. Obstet Gynecol. 2020;135:90S. doi:10.1097/01.aog.0000664076.39
   Web of Science ®Google Scholar
• Ni Y, Zhou X, Wu L, et al. Ovarian sertoli-leydig cell tumor, multinodular goiter, cystic nephromas and DICER1 mutations: case report and literature review. Pharmgenomics Pers Med. 2021;14:947–953. doi:10.2147/PGPM.S317153
   PubMed Web of Science ®Google Scholar
• Merideth MA, Harney LA, Vyas N, et al. Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1. Gynecol Oncol. 2020;156:647–653. doi:10.1016/j.ygyno.2019.12.037
   PubMed Web of Science ®Google Scholar
• Stewart CJR, Charles A, Foulkes WD. Gynecologic manifestations of the DICER1 syndrome. Surg Pathol Clin. 2016;9(2):227–241. doi:10.1016/j.path.2016.01.002
   PubMedGoogle Scholar
• Jonson AL, Geller MA, Dickson EL. Gonadal dysgenesis and gynecologic cancer. Obstet Gynecol. 2010;116(Supplement):550–552. doi:10.1097/aog.0b013e3181e4bfe
   PubMedGoogle Scholar
• Piazza MJ, Urbanetz AA. Germ cell tumors in dysgenetic gonads. Clinics. 2019;74:e408. doi:10.6061/clinics/2019/e408
   PubMed Web of Science ®Google Scholar
• Dicken BJ, Billmire DF, Krailo M, et al. Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: a report of the Children’s Oncology Group AGCT 0132 study. Pediatr Blood Cancer. 2017;65(4):e26913. doi:10.1002/pbc.26913
   Web of Science ®Google Scholar
• Yang W, Wu L, He Q, Zhang Y, Zhang Y, Tian Y. A case series of patients with gonadal dysgenesis-associated mixed malignant ovarian germ cell tumor. Gynecol Endocrinol. 2020;1–4. doi:10.1080/09513590.2020.1775194
   Web of Science ®Google Scholar
• Liu A-X, Shi H-Y, Cai Z-J, et al. Increased risk of gonadal malignancy and prophylactic gonadectomy: a study of 102 phenotypic female patients with Y chromosome or Y-derived sequences. Human Reprod. 2014;29(7):1413–1419. doi:10.1093/humrep/deu109
   PubMed Web of Science ®Google Scholar
• Vogt PH, Besikoglu B, Bettendorf M, et al. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY. Human Reprod. 2019;34(4):770–779. doi:10.1093/humrep/dez004
   PubMed Web of Science ®Google Scholar
• Capito C, Arnaud A, Hameury F, et al. Dysgerminoma and gonadal dysgenesis: the need for a new diagnosis tree for suspected ovarian tumours. J Pediatr Urol. 2011;7(3):367–372. doi:10.1016/j.jpurol.2011.02.021
   PubMed Web of Science ®Google Scholar
• Abacı A, Çatlı G, Berberoğlu M. Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development. J Pediatr Endocrinol Metabol. 2015;28:9–10. doi:10.1515/jpem-2014-0522
   Web of Science ®Google Scholar
• Lim GSD, Oliva E. The morphologic spectrum of uterine PEC-cell associated tumors in a patient with tuberous sclerosis. Int J Gynecol Pathol. 2011;121–128. doi:10.1097/pgp.0b013e3181fa5a9
   PubMed Web of Science ®Google Scholar
• Liang SX, Pearl M, Liu J, Hwang S, Tornos C. “Malignant” uterine perivascular epithelioid cell tumor, pelvic lymph node lymphangioleiomyomatosis, and gynecological pecomatosis in a patient with tuberous sclerosis. Int J Gynecol Pathol. 2008;27(1):86–90. doi:10.1097/pgp.0b013e318150df37
   PubMed Web of Science ®Google Scholar
• Nishio N, Kido A, Minamiguchi S, et al. MR findings of uterine PEComa in patients with tuberous sclerosis: report of two cases. Abdomin Radiol. 2019;44:1256–1260. doi:10.1007/s00261-019-01918-3
   PubMed Web of Science ®Google Scholar
• Gyure KA, Hart WR, Kennedy AW. Lymphangiomyomatosis of the uterus associated with tuberous sclerosis and malignant neoplasia of the female genital tract: a report of two cases. Int J Gynecol Pathol. 1995;14:344–351. doi:10.1097/00004347-199510000-00010
   PubMed Web of Science ®Google Scholar
• Jhawar S, Lakhotia R, Suzuki M, et al. Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1. Endocrinol Diabetes Metabol Case Rep. 2019;19–0040. doi:10.1530/EDM-19-0040
   PubMedGoogle Scholar
• Almeida MQ, Stratakis CA. Solid tumors associated with multiple endocrine neoplasias. Cancer Genet Cytogenet. 2010;203(1):30–36. doi:10.1016/j.cancergencyto.2010.09.006
   PubMedGoogle Scholar
• Spaulding R, Alatassi H, Stewart Metzinger D, Moghadamfalahi M. Ependymoma and carcinoid tumor associated with ovarian mature cystic teratoma in a patient with multiple endocrine neoplasia I. Case Rep Obstet Gynecol. 2014;2014:1–4. doi:10.1155/2014/712657
   Google Scholar
• Mele C, Mencarelli M, Caputo M, et al. Phenotypes associated with MEN1 syndrome: a focus on genotype-phenotype correlations. Front Endocrinol (Lausanne). 2020;11:591501. doi:10.3389/fendo.2020.591501
   PubMed Web of Science ®Google Scholar
• Liu Q, Tong D, Yuan W, et al. Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families. Medicine. 2017;96(3):e5967. doi:10.1097/MD.0000000000005967
   PubMed Web of Science ®Google Scholar
• Tamsen A, Mazur MT. Ovarian strumal carcinoid in association with multiple endocrine neoplasia, type IIA. Arch Pathol Lab Med. 1992;116(2):200–203.
   PubMed Web of Science ®Google Scholar
• Lou L, Zhou L, Wang W, Li H, Li Y. Atypical ovarian carcinoid tumor with widespread skeletal metastases: a case report of multiple endocrine neoplasia type 1 in a young woman. BMC Cancer. 2019;19(1). doi:10.1186/s12885-019-6332-7
   Web of Science ®Google Scholar
• Connor YD, Miao D, Lin DI, et al. Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: clinical features of a single family and comparison of large cohorts. Gynecol Oncol. 2020;159:131. doi:10.1016/j.ygyno.2019.10.031
   Web of Science ®Google Scholar
• Ramos P, Karnezis AN, Craig DW, et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet. 2014;46(5):427–429. doi:10.1038/ng.2928
   PubMed Web of Science ®Google Scholar
• Lin DI, Allen JM, Hecht JL, et al. SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association. Mod Pathol. 2019;32:1675–1687. doi:10.1038/s41379-019-0303-z
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Clarke BA, Hasselblatt M, Majewski J, Albrecht S, McCluggage WG. No small Surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour. J Pathol. 2014;233(3):209–214. doi:10.1002/path.4362
   PubMed Web of Science ®Google Scholar
• Witkowski L, Carrot-Zhang J, Albrecht S, et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet. 2014;46(5):438–443. doi:10.1038/ng.2931
   PubMed Web of Science ®Google Scholar
• Berchuck A, Witkowski L, Hasselblatt M, Foulkes WD. Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type. Gynecol Oncol Rep. 2015;12:20–22. doi:10.1016/j.gore.2015.02.002
   PubMed Web of Science ®Google Scholar
• Pejovic T, McCluggage WG, Krieg AJ, et al. The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type. Gynecol Oncol Rep. 2019;28:47–49. doi:10.1016/j.gore.2019.02.002
   PubMed Web of Science ®Google Scholar
• Blair VR, McLeod M, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020;21(8):e386– e397. doi:10.1016/s1470-2045(20)30219-9
   PubMed Web of Science ®Google Scholar
• Luo W, Fedda F, Lynch P, Tan D. CDH1 gene and hereditary diffuse gastric cancer syndrome: molecular and histological alterations and implications for diagnosis and treatment. Front Pharmacol. 2018;9. doi:10.3389/fphar.2018.01421
   Web of Science ®Google Scholar
• Kaurah P, Huntsman DG, et al. Hereditary diffuse gastric cancer. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews^®. Seattle: University of Washington, Seattle; 2002:1993–2021.
   Google Scholar
• Benusiglio PR, Malka D, Rouleau E, et al. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet. 2013;50(7):486–489. doi:10.1136/jmedgenet-2012-101472
   PubMed Web of Science ®Google Scholar
• Corso G, Intra M, Trentin C, Veronesi P, Galimberti V. CDH1 germline mutations and hereditary lobular breast cancer. Fam Cancer. 2016;15(2):215–219. doi:10.1007/s10689-016-9869-5
   PubMed Web of Science ®Google Scholar
• Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy consensus statement from the American Society of Breast Surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol. 2016;23(10):3106–3111. doi:10.1245/s10434-016-5408-8
   PubMed Web of Science ®Google Scholar
• Hutchcraft ML, Gallion HH, Kolesar JM. MUTYH as an emerging predictive biomarker in ovarian cancer. Diagnostics. 2021;11(1):84. doi:10.3390/diagnostics11010084
   Web of Science ®Google Scholar
• Win AK, Reece JC, Dowty JG, et al. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer. 2016;139(7):1557–1563. doi:10.1002/ijc.30197
   PubMed Web of Science ®Google Scholar
• Catalogue of Somatic Mutations in Cancer (COSMIC): MUTYH gene. Available from: https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=MUTYH. Accessed October 25, 2021.
   Google Scholar
• Vogt S, Jones N, Christian D, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137(6):1976–1985.e10. doi:10.1053/j.gastro.2009.08.052
   PubMed Web of Science ®Google Scholar
• Marini F, Falchetti A, Del Monte F, et al. Multiple endocrine neoplasia type 2. Orphanet J Rare Dis. 2006;1:45. doi:10.1186/1750-1172-1-45
   PubMed Web of Science ®Google Scholar
• Marini F, Falchetti A, Monte FD, et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis. 2006;1:38. doi:10.1186/1750-1172-1-38
   PubMed Web of Science ®Google Scholar
• Mirshahi UL, Kim J, Best AF, et al. A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance, and phenotype. JAMA Netw Open. 2021;4(2):e210112. doi:10.1001/jamanetworkopen.2021.0112
   PubMed Web of Science ®Google Scholar
• Wataya-Kaneda M, Tanaka M, Hamasaki T, Katayama I. Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients. PLoS One. 2013;8(5):e63910. doi:10.1371/journal.pone.0063910
   PubMed Web of Science ®Google Scholar
• Ebrahimi-Fakhari D, Mann LL, Poryo M, et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis. 2018;13:117. doi:10.1186/s13023-018-0870-y
   PubMed Web of Science ®Google Scholar